Cytomedix Inc (NASDAQOTCBB:CMXI)
CAPS Rating:
A biotechnology company that develops and licenses autologous cellular therapies, including Cytomedix's proprietary AutoloGel(tm) Process to produce a platelet rich plasma gel for the treatment of wounds.
RSS Headlines
Fool UK
Recs
what a terrible entry point CAPS gave me here. who cares though...I will make it work!